Literature DB >> 20729535

Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases.

E M Ruggeri1, F L Cecere2, L Moscetti3, L Doni2, D Padalino3, F Di Costanzo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20729535     DOI： 10.1093/annonc/mdq395

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Arsenic trioxide induced rhabdomyolysis, a rare but severe side effect, in an APL patient: a case report.

Authors:  Haiyan He; Ran An; Jian Hou; Weijun Fu
Journal:  Front Med       Date:  2017-04-19       Impact factor: 4.592

2.  A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma.

Authors:  Andrew D Liman; Vida A Passero; Agnes K Liman; Jenna Shields
Journal:  Case Rep Oncol Med       Date:  2018-07-19

3.  The changing spectrum of drug-induced myopathies.

Authors:  Frank L Mastaglia
Journal:  Acta Myol       Date:  2020-12-01

4.  A case of rhabdomyolysis related to sorafenib treatment for advanced hepatocellular carcinoma.

Authors:  Kunihiro Tsuji; Kenichi Takemura; Keisuke Minami; Ryota Teramoto; Keisuke Nakashima; Shinya Yamada; Hisashi Doyama; Hisanori Oiwake; Kenkou Hasatani
Journal:  Clin J Gastroenterol       Date:  2013-05-17

Review 5.  Drug induced rhabdomyolysis.

Authors:  Martin Hohenegger
Journal:  Curr Opin Pharmacol       Date:  2012-05-05       Impact factor: 5.547
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.